These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25592696)

  • 1. Developing imaging biomarkers for myocardial involvement in amyloidosis: challenge and opportunity.
    Udelson JE
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):60-62. PubMed ID: 25592696
    [No Abstract]   [Full Text] [Related]  

  • 2. 11C-Pittsburgh B PET imaging in cardiac amyloidosis.
    Lee SP; Lee ES; Choi H; Im HJ; Koh Y; Lee MH; Kwon JH; Paeng JC; Kim HK; Cheon GJ; Kim YJ; Kim I; Yoon SS; Seo JW; Sohn DW
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):50-59. PubMed ID: 25499132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear imaging for cardiac amyloidosis.
    Noordzij W; Glaudemans AW; Longhi S; Slart RH; Lorenzini M; Hazenberg BP; Rapezzi C
    Heart Fail Rev; 2015 Mar; 20(2):145-54. PubMed ID: 25424887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiography and magnetic resonance imaging in cardiac amyloidosis.
    von Kemp K; Beckers R; Vandenweghe J; Taeymans Y; Osteaux M; Block P
    Acta Cardiol; 1989; 44(1):29-36. PubMed ID: 2711796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality imaging of cardiac amyloidosis.
    Benz DC; Dorbala S
    Heart; 2024 May; 110(12):873-882. PubMed ID: 37586824
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of classical criteria for diagnosis of cardiac amyloidosis re-evaluated with magnetic resonance.
    Pozo E; Sanz J
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1133-6. PubMed ID: 25205232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters.
    Urbano-Moral JA; Gangadharamurthy D; Comenzo RL; Pandian NG; Patel AR
    Rev Esp Cardiol (Engl Ed); 2015 Aug; 68(8):657-64. PubMed ID: 26092748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac magnetic resonance imaging in amyloidosis].
    Domínguez A; Garrido N; Maceira A
    Rev Esp Cardiol; 2005 Sep; 58(9):1132-3. PubMed ID: 16185629
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel strategies for the diagnosis and treatment of cardiac amyloidosis.
    Palladini G; Milani P; Merlini G
    Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1195-211. PubMed ID: 26496239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impossible quest to make cardiac amyloidosis diagnosis easy.
    Canepa M; Tini G; Montecucco F
    Eur J Clin Invest; 2021 May; 51(5):e13512. PubMed ID: 33569771
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.
    Seeger A; Klumpp B; Kramer U; Stauder NI; Fenchel M; Claussen CD; Miller S
    Br J Radiol; 2009 Apr; 82(976):337-42. PubMed ID: 19029219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis.
    Clemmensen TS; Mølgaard H; Sörensen J; Eiskjaer H; Andersen NF; Mellemkjaer S; Andersen MJ; Tolbod LP; Harms HJ; Poulsen SH
    Eur J Heart Fail; 2017 Nov; 19(11):1457-1465. PubMed ID: 28836315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR findings in cardiac amyloidosis.
    vanden Driesen RI; Slaughter RE; Strugnell WE
    AJR Am J Roentgenol; 2006 Jun; 186(6):1682-5. PubMed ID: 16714659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive demonstration of cardiac involvement in acquired forms of systemic amyloidosis.
    Hind CR; Gibson DG; Lavender JP; Pepys MB
    Lancet; 1984 Jun; 1(8391):1417. PubMed ID: 6145870
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis.
    Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M
    Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenging Occam's Razor: An Unusual Combination of Sarcoidosis and Amyloidosis. The Value of Cardiac Magnetic Resonance Imaging in Infiltrative Cardiomyopathies.
    Nyktari E; Vassiliou VS; Arzanauskaite M; Gatehouse P; Greiser A; Wechalekar A; Gilbertson J; Pierce I; Sharma R; Mohiaddin R
    Can J Cardiol; 2017 Oct; 33(10):1335.e9-1335.e11. PubMed ID: 28870471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and molecular correlative imaging in a patient with amyloidosis.
    Pagourelias E; Delforge M; Claus P; Gheysens O
    Eur Heart J; 2016 Jun; 37(23):1834. PubMed ID: 26392436
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac amyloidosis.
    Yu CH; Lu YH; Lu JH
    QJM; 2019 Feb; 112(2):131-132. PubMed ID: 30476292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.